New avenues for improving pancreatic ductal adenocarcinoma (PDAC) treatment: Selective stroma depletion combined with nano drug delivery.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cancer Letters

• Publication date

  2015-12-28

• Fields of study

  Biology, Medicine, Materials Science, Engineering

• Identifiers
  DOI 10.1016/j.canlet.2015.09.007PMID 26415628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nanotherapeutics promises for colorectal cancer and pancreatic ductal adenocarcinoma

  2016cited by this paper
• Local iontophoretic administration of cytotoxic therapies to solid tumors

  2015cited by this paper
• The Basic Helix-Loop-Helix Transcription Factor E47 Reprograms Human Pancreatic Cancer Cells to a Quiescent Acinar State With Reduced Tumorigenic Potential

  2015cited by this paper
• Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance

  2015cited by this paper
• Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle.

  2015cited by this paper
• Whole genomes redefine the mutational landscape of pancreatic cancer

  2015cited by this paper
• Progress in the treatment of metastatic pancreatic cancer and the search for next opportunities.

  2015cited by this paper
• Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice

  2015cited by this paper
• Immune Therapy in GI Malignancies: A Review.

  2015cited by this paper
• Multidisciplinary management of pancreatic cancer.

  2015cited by this paper
• Multiple Layer‐by‐Layer Lipid‐Polymer Hybrid Nanoparticles for Improved FOLFIRINOX Chemotherapy in Pancreatic Tumor Models

  2015cited by this paper
• Addressing the challenges of pancreatic cancer: future directions for improving outcomes.

  2015cited by this paper
• nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial.

  2015cited by this paper
• Pancreatic cancer: from state-of-the-art treatments to promising novel therapies

  2015cited by this paper
• Solenopsin A and analogs exhibit ceramide-like biological activity

  2015cited by this paper
• Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein.

  2015cited by this paper
• Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.

  2014cited by this paper
• Progress in the knowledge and treatment of advanced pancreatic cancer: from benchside to bedside.

  2014cited by this paper
• Translational research in pancreatic ductal adenocarcinoma: current evidence and future concepts.

  2014cited by this paper
• Anticancer effects of gemcitabine are enhanced by co-administered iRGD peptide in murine pancreatic cancer models that overexpressed neuropilin-1

  2014cited by this paper
• Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy.

  2014cited by this paper
• The stromal compartments in pancreatic cancer: are there any therapeutic targets?

  2014cited by this paper
• Targeting Pancreatic Ductal Adenocarcinoma Acidic Microenvironment

  2014cited by this paper
• Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma.

  2014cited by this paper
• O-0003NAPOLI-1: RANDOMIZED PHASE 3 STUDY OF MM-398 (NAL-IRI), WITH OR WITHOUT 5-FLUOROURACIL AND LEUCOVORIN, VERSUS 5-FLUOROURACIL AND LEUCOVORIN, IN METASTATIC PANCREATIC CANCER PROGRESSED ON OR FOLLOWING GEMCITABINE-BASED THERAPY

  2014cited by this paper
• Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic Cancer

  2014cited by this paper
• Stromal uncertainties in pancreatic cancer

  2014cited by this paper
• Nab-paclitaxel: potential for the treatment of advanced pancreatic cancer

  2014cited by this paper
• Oncogenic KRAS signalling in pancreatic cancer

  2014cited by this paper
• Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.

  2014cited by this paper
• Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.

  2014cited by this paper
• Co-delivery of Cisplatin and Rapamycin for Enhanced Anticancer Therapy through Synergistic Effects and Microenvironment Modulation

  2014cited by this paper
• Tumour-stroma interactions in pancreatic ductal adenocarcinoma: rationale and current evidence for new therapeutic strategies.

  2014cited by this paper
• Galectin-1 as a therapeutic target in pancreatic cancer: the tumor stroma in the spotlight

  2014cited by this paper
• Pancreatic cancer and its stroma: a conspiracy theory.

  2014cited by this paper
• First-line nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer from routine clinical practice.

  2014cited by this paper
• Two-wave nanotherapy to target the stroma and optimize gemcitabine delivery to a human pancreatic cancer model in mice.

  2013cited by this paper
• Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells.

  2013cited by this paper
• Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

  2013cited by this paper
• Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia

  2013cited by this paper
• Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.

  2013cited by this paper
• Nanoparticle Albumin Bound Paclitaxel in the Treatment of Human Cancer: Nanodelivery Reaches Prime-Time?

  2013cited by this paper
• Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer.

  2013cited by this paper
• Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma

  2013cited by this paper
• A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma

  2013cited by this paper
• Unraveling the therapeutic potential of the Hedgehog pathway in cancer

  2013cited by this paper
• Using Functional Nanomaterials to Target and Regulate the Tumor Microenvironment: Diagnostic and Therapeutic Applications

  2013cited by this paper
• The desmoplastic stroma of pancreatic cancer is a barrier to immune cell infiltration

  2013cited by this paper
• Overcoming the stromal barrier for targeted delivery of HPMA copolymers to pancreatic tumors.

  2013cited by this paper
• Tumor–stroma interaction in orthotopic primary pancreatic cancer xenografts during hedgehog pathway inhibition

  2013cited by this paper
• Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma.

  2013cited by this paper
• SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice

  2013cited by this paper
• Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer

  2012cited by this paper
• Anti-Invasive Adjuvant Therapy with Imipramine Blue Enhances Chemotherapeutic Efficacy Against Glioma

  2012cited by this paper
• Cancer-Associated Fibroblasts Drive the Progression of Metastasis through both Paracrine and Mechanical Pressure on Cancer Tissue

  2012cited by this paper
• Multi-institutional experience with FOLFIRINOX in pancreatic adenocarcinoma.

  2012cited by this paper
• Unlike Pancreatic Cancer Cells Pancreatic Cancer Associated Fibroblasts Display Minimal Gene Induction after 5-Aza-2′-Deoxycytidine

  2012cited by this paper
• Overcoming the stromal barrier: technologies to optimize drug delivery in pancreatic cancer

  2012cited by this paper
• nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer.

  2012cited by this paper
• Dangerous liaisons: Pancreatic stellate cells and pancreatic cancer cells

  2012cited by this paper
• Desmoplasia in Pancreatic Cancer. Can We Fight It?

  2012cited by this paper
• Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.

  2012cited by this paper
• Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.

  2011cited by this paper
• The safety of IPI-926, a novel hedgehog pathway inhibitor, in combination with gemcitabine in patients (pts) with metastatic pancreatic cancer.

  2011cited by this paper
• CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans

  2011cited by this paper
• FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

  2011cited by this paper
• Pancreatic cancer.

  2010cited by this paper
• Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs

  2010cited by this paper
• Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner.

  2010cited by this paper
• Stromal biology and therapy in pancreatic cancer

  2010cited by this paper
• Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models

  2010cited by this paper
• Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells.

  2010cited by this paper
• New insights into alcoholic pancreatitis and pancreatic cancer

  2009cited by this paper
• SPARC: a matricellular regulator of tumorigenesis

  2009cited by this paper
• Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer

  2009cited by this paper
• Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma.

  2009cited by this paper
• Organotypic culture model of pancreatic cancer demonstrates that stromal cells modulate E-cadherin, beta-catenin, and Ezrin expression in tumor cells.

  2009cited by this paper
• Desmoplasia of pancreatic ductal adenocarcinoma.

  2009cited by this paper
• The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma.

  2008cited by this paper
• Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma

  2008cited by this paper
• Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance.

  2008cited by this paper
• Pancreatic cancer-associated stroma production.

  2007cited by this paper
• Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.

  2007cited by this paper
• Gemcitabine plus Bevacizumab no better than Gemcitabine alone in Clinical Study of 600 Patients with Pancreatic Cancer

  2007cited by this paper
• Fibroblasts in cancer

  2006cited by this paper
• Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells.

  2005cited by this paper
• Inflammation and cancer

  2002cited by this paper

• Evaluation of TRAM@PPF Nanoparticles for Efficacy Against Pancreatic Cancer in Mice Model.

  2026cites this paper
• Ultrasound-Triggered Piezocatalysis for Selectively Controlled NO Gas and Chemodrug Release to Enhance Drug Penetration in Pancreatic Cancer.

  2023cites this paper
• Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy

  2022cites this paper
• Tailor‐Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma

  2021cites this paper
• The Advance of Magnetic Resonance Elastography in Tumor Diagnosis

  2021cites this paper
• LAMC2 modulates the acidity of microenvironments to promote invasion and migration of pancreatic cancer cells via regulating AKT-dependent NHE1 activity.

  2020cites this paper
• Plasma medical oncology: Immunological interpretation of head and neck squamous cell carcinoma

  2020cites this paper
• Introduction to Active, Smart, and Intelligent Nanomaterials for Biomedical Application

  2020cites this paper
• High-matrix-stiffness induces promotion of hepatocellular carcinoma proliferation and suppression of apoptosis via miR-3682-3p-PHLDA1-FAS pathway

  2020cites this paper
• The Physical Microenvironment of Tumors: Characterization and Clinical Impact

  2020cites this paper
• Metformin-induced Stromal Depletion to Enhance the Penetration of Gemcitabine-Loaded Magnetic Nanoparticles for Pancreatic Cancer Targeted Therapy.

  2020cites this paper
• RETRACTED: Long noncoding RNA ITGB2‐AS1 promotes growth and metastasis through miR‐4319/RAF1 axis in pancreatic ductal adenocarcinoma

  2020cites this paper
• Antibiotic tigecycline inhibits cell proliferation, migration and invasion via down‐regulating CCNE2 in pancreatic ductal adenocarcinoma

  2020cites this paper
• Tracking Gold Nanorods’ Interaction with Large 3D Pancreatic-Stromal Tumor Spheroids by Multimodal Imaging: Fluorescence, Photoacoustic, and Photothermal Microscopies

  2020cites this paper
• Extracellular Matrix-Anchored Click Motifs for Specific Tissue Targeting.

  2019cites this paper
• Knowledge and biomarkers extraction system by integrating heterogeneous information sources

  2019cites this paper
• Cholesterol-tuned liposomal membrane rigidity directs tumor penetration and anti-tumor effect

  2019cites this paper
• Anti-Mesothelin Recombinant Immunotoxin Therapy for Colorectal Cancer.

  2019cites this paper
• Nanomedicine for Imaging and Therapy of Pancreatic Adenocarcinoma

  2019cites this paper
• Recent advances in “smart” delivery systems for extended drug release in cancer therapy

  2018cites this paper
• An Ensemble Framework Coping with Instability in the Gene Selection Process

  2018cites this paper
• Stroma - A Double-Edged Sword in Pancreatic Cancer: A Lesson From Targeting Stroma in Pancreatic Cancer With Hedgehog Signaling Inhibitors.

  2018cites this paper
• From Friend to Enemy: Dissecting the Functional Alteration of Immunoregulatory Components during Pancreatic Tumorigenesis

  2018cites this paper
• A data mining framework based on boundary-points for gene selection from DNA-microarrays: Pancreatic Ductal Adenocarcinoma as a case study

  2018cites this paper
• Evaluating the diagnostic and prognostic value of long non-coding RNA SNHG15 in pancreatic ductal adenocarcinoma.

  2018cites this paper
• An Ensemble Approach for Gene Selection in Gene Expression Data

  2017cites this paper
• Viscoelastic properties of human pancreatic tumors and in vitro constructs to mimic mechanical properties.

  2017cites this paper
• Mixed poly(vinyl pyrrolidone)‐based drug‐loaded nanomicelles shows enhanced efficacy against pancreatic cancer cell lines

  2017cites this paper
• Tenascin-C induces migration and invasion through JNK/c-Jun signalling in pancreatic cancer

  2017cites this paper
• Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma.

  2017cites this paper
• Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1 axis.

  2017cites this paper
• Neovascular Prostate-Specific Membrane Antigen Expression Is Associated with Improved Overall Survival under Palliative Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma

  2017cites this paper
• Cytotoxic potentials of biologically fabricated platinum nanoparticles from Streptomyces sp. on MCF-7 breast cancer cells.

  2017cites this paper
• Synthesis and characterization of Zinc Oxide nanoparticles using marine Streptomyces sp. with its investigations on anticancer and antibacterial activity

  2017cites this paper
• Thermosensitive Liposomal Codelivery of HSA-Paclitaxel and HSA-Ellagic Acid Complexes for Enhanced Drug Perfusion and Efficacy Against Pancreatic Cancer.

  2017cites this paper
• Aptamers as smart ligands for nano-carriers targeting

  2016cites this paper
• Intraperitoneal Administration of Biointerface‐Camouflaged Upconversion Nanoparticles for Contrast Enhanced Imaging of Pancreatic Cancer

  2016cites this paper
• Enhancing synergy of CAR T cell therapy and oncolytic virus therapy for pancreatic cancer

  2016cites this paper
• A Platform for Rapid, Quantitative Assessment of Multiple Drug Combinations Simultaneously in Solid Tumors In Vivo

  2016cites this paper
• Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification

  2016cites this paper